Suppr超能文献

口服副干酪乳杆菌NCC 2461对草花粉过敏性鼻炎的调节作用:花粉季节的一项随机、安慰剂对照研究。

Oral administration of Lactobacillus paracasei NCC 2461 for the modulation of grass pollen allergic rhinitis: a randomized, placebo-controlled study during the pollen season.

作者信息

Nembrini Chiara, Singh Anurag, De Castro Carlos Antonio, Mercenier Annick, Nutten Sophie

机构信息

Nestlé Research Center, Nestec Ltd, PO Box 44, 1000 Lausanne-26, Switzerland.

出版信息

Clin Transl Allergy. 2015 Dec 9;5:41. doi: 10.1186/s13601-015-0085-4. eCollection 2015.

Abstract

BACKGROUND

The efficacy of Lactobacillus paracasei NCC 2461 in modulating allergic rhinitis was previously evaluated in two exploratory clinical studies. Oral administration with NCC 2461 reduced specific subjective symptoms following nasal provocation tests with controlled grass pollen allergen concentrations. Our aim was to confirm the anti-allergic effect of NCC 2461 in grass pollen allergic subjects exposed to natural doses of allergens during the pollen season.

FINDINGS

A double-blind, randomized, placebo-controlled, parallel study was conducted with 131 grass pollen allergic subjects from May to July 2012 in concomitance with the pollen season in Berlin. NCC 2461 or placebo was administered daily for an 8-week period to adult subjects with clinical history of allergic rhinitis to grass pollen, positive skin prick test and IgE to grass pollen. During the 8 weeks, symptoms and quality of life questionnaires were filled out, and plasma was collected for IgE analysis at screening and at the end of the intervention. All subjects were included within a 5-day interval, ensuring exposure to similar air pollen counts for each individual during the trial period. The results obtained show that symptoms increased with pollen loads, confirming a natural exposure to the allergen and presence of pollen-induced allergic rhinitis in the subjects. However, no significant differences were observed in allergic rhinitis symptoms scores, quality of life, or specific IgE levels between subjects receiving NCC 2461 as compared to placebo administration.

CONCLUSION

In contrast to previous findings, oral administration of NCC 2461 did not show a beneficial effect on allergic rhinitis in a field trial. The influence of study design, allergen exposure and intervention window on the efficacy of NCC 2461 in modulating respiratory allergy should be further evaluated.

摘要

背景

先前在两项探索性临床研究中评估了副干酪乳杆菌NCC 2461调节过敏性鼻炎的功效。口服NCC 2461可减轻在使用受控草花粉过敏原浓度进行鼻激发试验后的特定主观症状。我们的目的是确认NCC 2461对在花粉季节接触天然剂量过敏原的草花粉过敏受试者的抗过敏作用。

研究结果

2012年5月至7月,在柏林花粉季节期间,对131名草花粉过敏受试者进行了一项双盲、随机、安慰剂对照的平行研究。对有草花粉过敏性鼻炎临床病史、草花粉皮肤点刺试验阳性和对草花粉IgE阳性的成年受试者,每天给予NCC 2461或安慰剂,为期8周。在这8周内,填写症状和生活质量问卷,并在筛查时和干预结束时采集血浆进行IgE分析。所有受试者在5天的间隔内入组,以确保在试验期间每个个体接触的空气花粉计数相似。获得的结果表明,症状随花粉负荷增加,证实受试者自然接触了过敏原且存在花粉诱导的过敏性鼻炎。然而,与给予安慰剂相比,接受NCC 2461的受试者在过敏性鼻炎症状评分、生活质量或特异性IgE水平方面未观察到显著差异。

结论

与先前的研究结果相反,在一项现场试验中,口服NCC 2461对过敏性鼻炎未显示出有益效果。应进一步评估研究设计、过敏原暴露和干预窗口对NCC 2461调节呼吸道过敏功效的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b44a/4673783/28032128edc5/13601_2015_85_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验